Healthcare / Medical Care FacilitiesBSE
$53.36
-1.22 (-2.21%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $6.2M · quality 45.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
16/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.0B
P/E
24.1x
↑EV/EBITDA
20.9x
↑ROE
12.0%
↑Gross Margin
N/A
•Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
-44.9%
FCF margin
—
FCF / Net income
0.15x
Latest source
Provider fallback
Margin decomposition
Último año: revenue — · net income $41.4M · FCF $6.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | — | — | $588.5M | $858.1M |
| Net Income | $41.4M | $41.4M | $3.9M | $453.2M | $-154.8M |
| EBITDA | $47.3M | $47.3M | $5.8M | $636.7M | $112.1M |
| EPS | — | — | 0.21 | 24.18 | -8.26 |
| Gross Margin | — | — | — | 85.1% | 85.2% |
| Operating Margin | — | — | — | -17.7% | -8.5% |
| Net Margin | — | — | — | 77.0% | -18.0% |
| Balance Sheet | |||||
| Debt/Equity | — | — | — | — | 0.72 |
| Current Ratio | 11.33 | 11.33 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $6.2M | $6.2M | $15.4M | $-96.0M | $37.3M |
| Returns | |||||
| ROE | 12.0% | 12.0% | 1.3% | 41.4% | -24.1% |
| Valuation | |||||
| P/E | 24.14 | 24.14 | 400.10 | — | — |
| EV/EBITDA | 20.89 | 20.89 | 270.85 | — | — |
| P/B | 2.91 | 2.91 | 5.19 | — | — |
| Growth & Yield | |||||
| Revenue Growth | — | — | — | -31.4% | — |
| EPS Growth | — | — | -99.1% | 392.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-27.9%
Start / end P/E
n/dx → n/dx
EPS bridge
0.21 → n/d
Residual
-27.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.